HAL (France)
open access
Novel non-stimulants rescue hyperactive phenotype in an adgrl3.1 mutant zebrafish model of ADHD
ADHD is a highly prevalent neurodevelopmental disorder. The first-line therapeutic for ADHD, methylphenidate, can cause serious side effects including weight loss, insomnia, and hypertension. Therefore, the development of non-stimulant-based therapeutics has been prioritized. However, many of these
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Schizophrenia-Associated Gene Mutations Produce Distinct Behavioral and Neural Phenotypes in Zebrafish#1092503
- Schizophrenia-Associated Gene Mutations Produce Distinct Behavioral and Neural Phenotypes in Zebrafish#1092487
- 2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)#1088343
- The Role of DNA Methylation and ZBTB Transcription Factors in Sex Differentiation, Maintenance and Heat‐Induced Masculinization in Zebrafish#354038
- Neurobehavioural genes exert indirect genetic effects on blood lipid profiles through behavioural traits.#988587
Record · ID 1537740
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive